MDCT appearance of gastrointestinal stromal tumors after therapy with imatinib mesylate

被引：14
|
作者：
Warakaulle, DR [1 ]
Gleeson, F [1 ]
机构：
[1] Churchill Hosp, Dept Radiol, Oxford OX3 7LJ, England
来源：
AMERICAN JOURNAL OF ROENTGENOLOGY | 2006年 / 186卷 / 02期
关键词：
CT; gastrointestinal imaging; gastrointestinal stromal tumors; imatinib mesylate; oncologic imaging;
D O I：
10.2214/AJR.04.1516
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OBJECTIVE. Our objective was to determine the MDCT appearance of gastrointestinal stromal tumors (GISTs) after treatment with imatinib mesylate. CONCLUSION. Cystic changes within primary and metastatic GISTs seen on MDCT in patients after imatinib mesylate therapy are evidence of disease response. Calcification may also occur in lesions that respond to therapy.
引用
收藏
页码：510 / 515
页数：6
相关论文
共 50 条
  • [41] Surgical treatment of patients with initially inoperable and/or metastatic gastrointestinal stromal tumors (GIST) during therapy with imatinib mesylate
    Rutkowski, P
    Nowecki, Z
    Nyckowski, P
    Dziewirski, W
    Grzesiakowska, U
    Nasierowska-Guttmejer, A
    Krawczyk, M
    Ruka, W
    JOURNAL OF SURGICAL ONCOLOGY, 2006, 93 (04) : 304 - 311
  • [42] Advanced gastrointestinal stromal tumors successfully treated with imatinib mesylate: A report of two cases
    Hasan, S
    Hassan, M
    Oke, L
    Dinh, K
    Onojobi, G
    Lombardo, F
    Dawkins, F
    Jack, M
    JOURNAL OF THE NATIONAL MEDICAL ASSOCIATION, 2003, 95 (12) : 1208 - 1210
  • [43] Secondary resistance of extra-gastrointestinal stromal tumors to imatinib mesylate: Report of a case
    Ando, Koji
    Oki, Eiji
    Sugiyama, Masahiko
    Zhao, Yan
    Kojima, Aya
    Yamamoto, Hidetaka
    Yamashita, Yoichi
    Saeki, Hiroshi
    Taketomi, Akinobu
    Morita, Masaru
    Kakeji, Yoshihiro
    Tsujitani, Shunichi
    Maehara, Yoshihiko
    SURGERY TODAY, 2011, 41 (09) : 1290 - 1293
  • [44] Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors
    Tonyali, Onder
    Coskun, Ugur
    Yildiz, Ramazan
    Karakan, Tarkan
    Demirci, Umut
    Akyurek, Nalan
    Benekli, Mustafa
    Buyukberber, Suleyman
    MEDICAL ONCOLOGY, 2010, 27 (03) : 768 - 773
  • [45] Preoperative imatinib mesylate for unresectable or locally advanced primary gastrointestinal stromal tumors (GIST)
    Fiore, M.
    Palassini, E.
    Fumagalli, E.
    Pilotti, S.
    Tamborini, E.
    Stacchiotti, S.
    Pennacchioli, E.
    Casali, P. G.
    Gronchi, A.
    EJSO, 2009, 35 (07): : 739 - 745
  • [46] Imatinib mesylate-induced acute liver failure in a patient with gastrointestinal stromal tumors
    Onder Tonyali
    Ugur Coskun
    Ramazan Yildiz
    Tarkan Karakan
    Umut Demirci
    Nalan Akyurek
    Mustafa Benekli
    Suleyman Buyukberber
    Medical Oncology, 2010, 27 : 768 - 773
  • [47] Imatinib mesylate treatment in a dog with gastrointestinal stromal tumors with a c-kit mutation
    Irie, Mitsuhiro
    Takeuchi, Yoshinori
    Ohtakei, Yuzo
    Suzukii, Hitomi
    Nagata, Nao
    Miyoshi, Takuma
    Kagawa, Yumiko
    Yamagami, Tetsushi
    JOURNAL OF VETERINARY MEDICAL SCIENCE, 2015, 77 (11): : 1535 - 1539
  • [48] Some lessons learned from imatinib mesylate clinical development in gastrointestinal stromal tumors
    Casali, PG
    Bertulli, R
    Fumagalli, E
    Coco, P
    Grosso, F
    Stacchiotti, S
    JOURNAL OF CHEMOTHERAPY, 2004, 16 : 55 - 58
  • [49] Imatinib mesylate activates IGFBP3 expression in gastrointestinal stromal tumors.
    Dupart, J
    Trent, JC
    Cohen, P
    Zhang, W
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8987S - 8987S
  • [50] Secondary resistance of extra-gastrointestinal stromal tumors to imatinib mesylate: Report of a case
    Koji Ando
    Eiji Oki
    Masahiko Sugiyama
    Yan Zhao
    Aya Kojima
    Hidetaka Yamamoto
    Yoichi Yamashita
    Hiroshi Saeki
    Akinobu Taketomi
    Masaru Morita
    Yoshihiro Kakeji
    Shunichi Tsujitani
    Yoshihiko Maehara
    Surgery Today, 2011, 41 : 1290 - 1293
12345